Chemed (CHE) reported Q2 adjusted earnings late Tuesday of $6.06 per diluted share, up from $4.27 a year earlier.

Analysts polled by FactSet expected $5.60.

Revenue for the three months ended June 30 was $673.3 million, up from $618.8 million. a year earlier.

Analysts surveyed by FactSet expected $665 million.

For the full-year 2026, the company now expects adjusted EPS of $25 to $25.75 compared with $24 to $24.75 earlier.

Analysts expect $24.24.